nach oben

01.12.2015 | Original Article

¹⁸F-FDG PET/CT in patients with adult-onset Still’s disease

verfasst von: Meng-Jie Dong, Cai-qin Wang, Kui Zhao, Guo-Lin Wang, Mei-Ling Sun, Zhen-Feng Liu, Liqin Xu

Erschienen in: Clinical Rheumatology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) has become useful for the detection and diagnosis of inflammatory conditions, including rheumatic diseases, immunoglobulin (Ig) G4-related disease and giant cell arteritis. However, few articles based on small sample sizes (n = 7) diagnosed as adult-onset Still’s disease (AOSD) have been published. The study aim was to observe the reliable characteristics and usefulness of ¹⁸F-FDG PET/CT for the evaluation of consecutive patients with AOSD. Eligible patients were selected from among those who had undergone ¹⁸F-FDG PET/CT between May 2007 and June 2014. Twenty-six consecutive AOSD patients were recruited retrospectively according to criteria set by Yamaguchi et al. All patients underwent evaluation by ¹⁸F-FDG PET/CT. The characteristics and usefulness of ¹⁸F-FDG PET/CT for evaluation of consecutive patients with AOSD were evaluated. All 26 patients had ¹⁸F-FDG-avid lesion(s) related to their particular disease. Diffuse and homogeneous accumulation of ¹⁸F-FDG was seen in the bone marrow (26/26; 100 %; maximum standardized uptake (SUV_max), 2.10–6.73) and spleen (25/26; 96.15 %). The SUV_max of affected lymph nodes was 1.3–9.53 (mean ± SD, 4.12 ± 2.24). The SUV_max and size factors (maximum diameter and areas) of affected lymph nodes were significantly different (P = 0.033 and P = 0.012, respectively). ¹⁸F-FDG PET/CT showed the general distribution of ¹⁸F-FDG accumulation. This factor helped to exclude malignant disease and aided the diagnosis of AOSD (42.3 %) in 11 cases when combined with clinical features and aided decisions regarding appropriate biopsy sites, such as the lymph nodes (n = 9) and bone marrow (n = 13). ¹⁸F-FDG PET/CT is a unique imaging method for the assessment of metabolic activity throughout the body in subjects with AOSD. Characteristics or patterns of AOSD observed on ¹⁸F-FDG PET/CT can be used for the indication and diagnosis or to guide the clinical management of ASOD.

Mahroum N, Mahagna H, Amital H (2014) Diagnosis and classification of adult Still’s disease. J Autoimmun 48–49:34–37CrossRefPubMed

Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’ s disease. Ann Rheum Dis 65:564–572PubMedCentralCrossRefPubMed

Besson FL, de Boysson H, Parienti JJ, Bouvard G, Bienvenu B, Agostini D (2014) Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case–control study. Eur J Nucl Med Mol Imaging 41:155–166CrossRefPubMed

Gupta P, Ponzo F, Kramer EL (2005) Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules. Clin Rheumatol 24:402–405CrossRefPubMed

Moreno D, Yuste JR, Rodriguez M, García-Velloso MJ, Prieto J (2005) Positron emission tomography use in the diagnosis and follow up of Takayasu’s arteritis. Ann Rheum Dis 64:1091–1093PubMedCentralCrossRefPubMed

Blockmans D, de Ceuninck L, Vandershueren S, Knockaert D, Mortelmans L, Bobbaers H (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137CrossRefPubMed

Takahashi H, Yamashita H, Morooka M, Kubota K, Takahashi Y, Kaneko H, Kano T, Mimori A (2014) The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease. Joint Bone Spine 81(4):331–336CrossRefPubMed

Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed

Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I, Broussolle C, Sève P (2014) Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore) 93:91–99CrossRef

10.

Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T (2007) Adult-onset Still’s disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Ageing 36:104–106CrossRefPubMed

11.

Ichiki H, Shishido M, Nishiyama S (1992) Two cases of adult onset of Still’s disease in the elderly. Nihon Ronen Igakkai Zasshi 29:960–964CrossRefPubMed

12.

Mavragani CP, Spyridakis EG, Koutsilieris M (2012) Adult-onset still’s disease: from pathophysiology to targeted therapies. Int J Inflamm 2012:879020CrossRef

13.

Nagai Y, Hasegawa M, Okada E, Hattori T, Tago O, Ishikawa O (2012) Clinical follow-up study of adult-onset Still’s disease. J Dermatol 39:898–901CrossRefPubMed

14.

Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F (2010) Adult-onset still’s disease. Rheumatol Int 30:855–862CrossRefPubMed

15.

Nishiyama Y, Yamamoto Y, Dobashi H, Kameda T (2010) Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease. Jpn J Radiol 28:405–413CrossRefPubMed

16.

Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A (2013) The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013:623036PubMedCentralCrossRefPubMed

17.

Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, Kano T, Mimori A (2014) Clinical value of 18F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still’s disease: a seven-case series and review of the literature. Mod Rheumatol 24:645–650CrossRefPubMed

18.

de Graaff LC, ten Broek MR, Schweitzer DH (2012) Is Still’s disease still one disease? A case of adult-onset Still’s disease showing accumulation in the carotids and the large vessels of the legs on positron emission tomography: CT images. Rheumatol Int 32:2487–2490CrossRefPubMed

19.

Funauchi M, Ikoma S, Kishimoto K, Shimazu H, Nozaki Y, Sugiyama M, Kinoshita K (2008) A case of adult onset Still’s disease showing marked accumulation in the liver and spleen, on positron emission tomography-CT images. Rheumatol Int 28:1061–1064CrossRefPubMed

20.

Choe JY, Chung DS, Park SH, Kwon HH, Kim SK (2010) Clinical significance of 18F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still’s disease: report of two cases and review of literatures. Rheumatol Int 30:1673–1676CrossRefPubMed

21.

Murata Y, Kubota K, Yukihiro M, Ito K, Watanabe H, Shibuya H (2006) Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Nucl Med Biol 33:999–1004CrossRefPubMed

22.

Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30:269–291CrossRefPubMed

23.

Cremers JP, Van Kroonenburgh MJ, Mostard RL, Vöö SA, Wijnen PA, Koek GH, Drent M (2014) Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 31:37–45PubMed

24.

Oh JR, Song HC, Kang SR, Yoo SW, Kim J, Chong A, Min JJ, Bom HS, Lee SS, Park YW (2011) The clinical usefulness of (18) F-FDG PET/CT in patients with systemic autoimmune disease. Nucl Med Mol Imaging 45:177–184PubMedCentralCrossRefPubMed

25.

Dong MJ, Zhao K, Liu ZF, Wang GL, Yang SY, Zhou GJ (2011) A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin. Eur J Radiol 80:834–844CrossRefPubMed

26.

Nilegaonkar S, Karekar R, Hirawe D, Lagade S (2012) Adult onset Still’s disease: role of scintigraphy. Indian J Nucl Med 27:48–49PubMedCentralCrossRefPubMed

27.

Takeshita T, Kaminaga T, Ohkuma M, Furui S (2006) Adult-onset Still’s disease: evaluation by gallium-67 citrate scintigraphy. Intern Med 45:937–938CrossRefPubMed

Titel: 18F-FDG PET/CT in patients with adult-onset Still’s disease
verfasst von: Meng-Jie Dong
Cai-qin Wang
Kui Zhao
Guo-Lin Wang
Mei-Ling Sun
Zhen-Feng Liu
Liqin Xu
Publikationsdatum: 01.12.2015
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 12/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-015-2901-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen